Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $9.50 by Analysts at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOXFree Report) had its price target lowered by Canaccord Genuity Group from $10.00 to $9.50 in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock.

Several other analysts also recently weighed in on BIOX. Oppenheimer cut their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Roth Mkm cut their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Lake Street Capital cut their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $12.13.

Get Our Latest Report on Bioceres Crop Solutions

Bioceres Crop Solutions Trading Down 3.8 %

NASDAQ BIOX traded down $0.26 on Wednesday, hitting $6.58. The company’s stock had a trading volume of 41,097 shares, compared to its average volume of 88,466. The company has a current ratio of 1.24, a quick ratio of 0.86 and a debt-to-equity ratio of 0.35. The firm has a market cap of $413.55 million, a P/E ratio of 330.67 and a beta of 0.49. The company’s 50-day simple moving average is $7.66 and its 200 day simple moving average is $9.83. Bioceres Crop Solutions has a 52-week low of $5.71 and a 52-week high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the previous year, the company earned ($0.07) earnings per share. Research analysts predict that Bioceres Crop Solutions will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Fourth Sail Capital LP increased its stake in shares of Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after purchasing an additional 1,209,277 shares in the last quarter. Long Focus Capital Management LLC increased its position in Bioceres Crop Solutions by 19.9% in the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after buying an additional 46,647 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions in the second quarter worth about $472,000. Ping Capital Management Inc. purchased a new position in shares of Bioceres Crop Solutions during the 2nd quarter valued at about $448,000. Finally, Lazard Asset Management LLC bought a new position in shares of Bioceres Crop Solutions during the 1st quarter valued at approximately $212,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.